Shanghai Haohai Biological Technology Co., Ltd.

HK$16.01As of Sun 8 Nov 2026, 12:00 UTC
HKEX:6826Healthcare
Country Hong Kong
PE (Fwd) •••
TSR 10Y CAGR (2.58%)
Div yield 7.29%
ROE 1.32%
Biotechnology
Beta (5Y) 0.42
PE TTM 28.74
TSR TTM (38.19%)
Mkt cap HK$7.256B
ROIC 2.12%
SE Grade™
Value
Quality
Moat
Consensus
Reference
$19
17.08%
47.45%
Hold 12|2|6|12|12
4Q25
1Q26
2Q26
3Q26
Earnings per share¥
0.23
0.22
0.23
0.23
11.44%
5.64%
16.33%
5.52%
Revenue¥M
733.1
753.1
785.8
810.3
(1.22%)
2.41%
7.26%
10.49%
Peers (US$925.5M)
Cap (US$)
PE
Capital
TTM
5Y
10Y
Leveragex
0.641
(0.026)
(0.023)
EBIT/Intx
5.078
0.365
0.349
Own earn%
(3.25)
7.39
3.43
Sh yield%
41.60
9.66
9.86
Owners
Insiders/Inst%
2.47
50.28
Short interest%
4.13
SBC / revenue%
0.64
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
11
Op margin range%
26–32
$1 testx
0.1
Incr. ROIC%
19